The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.65

Today's change-1.23 -2.87%
Updated May 5 4:02 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.65

Today's change-1.23 -2.87%
Updated May 5 4:02 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA crosses below 50-day moving average

Fresenius Medical Care AG & Co KGaA closed sharply lower Tuesday, dropping (U.S.)$1.23 or 2.87% to (U.S.)$41.65 and crossing below its 50-day moving average. Shares have lost 2.32% over the last five days, but have gained 12.14% over the last year to date. This security has outperformed the S&P 500 by 10.63% during the last year.

Key company metrics

  • Open(U.S.) $42.25
  • Previous close(U.S.) $42.88
  • High(U.S.) $42.30
  • Low(U.S.) $41.54
  • Bid / Ask-- / --
  • YTD % change+12.14%
  • Volume186,421
  • Average volume (10-day)162,970
  • Average volume (1-month)153,450
  • Average volume (3-month)154,789
  • 52-week range(U.S.) $31.28 to (U.S.) $43.93
  • Beta0.45
  • Trailing P/E24.16×
  • P/E 1 year forward23.33×
  • Forward PEG2.43×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.27%
  • Trailing EPS(U.S.) $1.72
Updated May 5 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.96%

Based on its net profit margin of 7.96%, Fresenius Medical Care AG & Co KGaA is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.26%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue4,3204,1133,8353,564
Total other revenue--------
Total revenue4,3204,1133,8353,564
Gross profit1,4141,2881,2111,082
Total cost of revenue2,9062,8252,6232,481
Total operating expense3,6573,5233,2793,119
Selling / general / administrative724670631620
Research & development31303130
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-1100
Other operating expenses, total--------
Operating income663590556445
Interest income (expense), net non-operating-162-111-111-112
Gain (loss) on sale of assets--------
Other--------
Income before tax546491458349
Income after tax403329281247
Income tax, total143162177101
Net income335271234205
Total adjustments to net income------0
Net income before extra. items335271234205
Minority interest-67-58-47-42
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items335271234205
Inc. avail. to common incl. extra. items335271234205
Diluted net income335271234205
Dilution adjustment------0
Diluted weighted average shares304303302302
Diluted EPS excluding extraordinary itemsvalue per share1.100.890.770.68
Dividends per sharevalue per share0.530.000.000.00
Diluted normalized EPSvalue per share1.100.900.770.68